Benjamin Chin-Yee

Philosophy & Humanities

**A little bit of cancer? Ergo 2026**

**The death of the consult note. JAMA 2026**

**On the uses and abuses of biomarkers in clinical reasoning. Studies in History and Philosophy of Science 2026**

**The power of the ‘C’ word. Aeon 2025**

**Teaching gentle medicine. Journal of Internal Medicine 2025**

**Minimal residual disease: premises before promises. Biology & Philosophy 2024**

**Generalizations in clinical trials—do generics help or harm? Kennedy Institute of Ethics Journal 2024**

**Cancer medicine and precision oncology. Handbook of the Philosophy of Medicine 2024**

**Concepts of actionability in precision oncology. Philosophy of Science 2023**

**Technical difficulties: teaching critical philosophical orientations toward technology. Teaching and Learning in Medicine 2022**

**COVID-19, digital health technology and the politics of the unprecedented. Big Data & Society 2021**

**Thirty years of teaching evidence-based medicine: have we been getting it all wrong? Advances in Health Sciences Education 2021**

**What is “shared” in shared decision making? Journal of Evaluation in Clinical Practice 2020**

**Three problems with big data and artificial intelligence in medicine. Perspectives in Biology and Medicine 201**9

**From hermeneutics to heteroglossia: ‘The Patient’s View’ revisited. Medical Humanities 2019**

**Three visions of doctoring: a Gadamerian dialogue. Advances in Health Sciences Education 2018**

**Clinical judgement in the era of big data and predictive analytics. Journal of Evaluation in Clinical Practice 2018**

Science & Medicine

**Cancer labeling, risk perception, and treatment choices in clonal cytopenia of undetermined significance. JAMA Network Open 2025**

**Generalization bias in large language model summarization of scientific research. Royal Society Open Science 2025**

**Epistemic limitations of measurable residual disease in haematological malignancies. Lancet Haematology 2025**

**Paroxysmal nocturnal hemoglobinuria in pregnancy treated with pegcetacoplan. EJHaem 2025**

**Hasty generalizations and generics in medical research: a systematic review. PLOS One 2024**

**Finding Goldilocks: Choosing Wisely Together in hematology-oncology. JCO Oncology Practice 2024**

A rational approach to JAK2 mutation testing in patients with elevated hemoglobin: results from the JAK2 Prediction Cohort (JAKPOT) study. Journal of General Internal Medicine 2023

**Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review. CMAJ Open 2022**

**The impact of artificial intelligence on health equity in oncology: scoping review. Journal of Medical Internet Research 2022**

**T-cell clonality testing for the diagnosis of T-cell large granular lymphocytic leukemia: Are we identifying pathology or incidental clones? International Journal of Laboratory Hematology 2022**

**Successful treatment of imatinib-induced periorbital edema with a sodium-glucose cotransporter-2 inhibitor. Annals of Hematology 2022**

**Serum erythropoietin levels in 696 patients investigated for erythrocytosis with JAK2 mutation analysis. American Journal of Hematology 2022**

**Erythrocytosis induced by sodium-glucose cotransporter-2 inhibitors. Canadian Medical Association Journal 2020**

**Genomic data in prognostic models — what is lost in translation? British Journal of Haematology 2019**

© Copyright Benjamin Chin-Yee (2025)